Skip to content

LONA LONA Current ratio

Current ratio at other companies

Eli Lilly logo
Eli LillyLLY
1.5×+0.1×
Arvinas logo
ArvinasARVN
5.4×+0.9×
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
10.9×-4.3×
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
7.1×-4.0×
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
6.5×+1.3×
Erasca, Inc. logo
Erasca, Inc.ERAS
9.5×-2.8×

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+235%
Enterprise value$54.18M

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0.0×

Where this comes from

Calculated from LONA’s reported figures.

Based on the most recent quarter.

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's current ratio?
LONA (LONA) reported current ratio of 10.4× in Q1 2026.
How has LONA's current ratio changed year-over-year?
LONA's current ratio increased by 43.1% year-over-year, from 7.3× to 10.4×.
What is the long-term trend for LONA's current ratio?
Over 5 years (2020 to 2025), LONA's current ratio has grown at a -46.7% compound annual growth rate (CAGR), from 43.7× to 1.9×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.